[A case of anastomotic recurrence of gastric cancer who underwent esophagojejunostomy, treated with S-1 monotherapy leading to complete response (CR)].
A 67-year-old male with an anastomotic recurrence of gastric cancer who underwent esophagojejunostomy, was treated with S-1 monotherapy leading to a complete response (CR). The patient was diagnosed with gastric cardia cancer and underwent a total gastrectomy with lymph node dissection. Two years and 2 months after surgery, the patient was administered S-1 100 mg/day (4-week administration and 2-week rest) because anastomotic recurrence was confirmed. The patient was unable to take anything by mouth, but this chemotherapy could be orally administered after one course. After six courses, tumor tissue completely disappeared and he had a CR. Administration of S-1 was continued for eight courses and then discontinued. There was no relapse for two years after discontinuation.
Kimura
Kenjiro
K
Dept. of Surgery, Fuchu Hospital.
Takeuchi
Kazuhiro
K
Ohkita
Hirohito
H
Aomatsu
Naoki
N
Hirata
Keichiro
K
Nishii
Takafumi
T
Kosaka
Kinnshi
K
Tei
Seika
S
Uchima
Yasutake
Y
Tanaka
Hajime
H
D000368:Aged; D003131:Combined Modality Therapy; D004338:Drug Combinations; D005763:Gastroenterostomy; D005773:Gastroscopy; D006801:Humans; D008297:Male; D010094:Oxonic Acid / Q000627:therapeutic use*; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D005641:Tegafur / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid